Key result
Clopidogrel therapy in an 80-year-old man with chronic kidney disease resulted in severe neutropenia and sepsis after 55 days, which resolved upon switching to ticagrelor.
Why the study?
Neutropenia is a rare but serious adverse effect of clopidogrel, and it is unknown whether this adverse effect is associated with impaired kidney function.
Case Report (n=1)
No
Clopidogrel can cause severe, potentially life-threatening neutropenia, particularly in patients with chronic kidney disease, requiring vigilant hematologic monitoring.
Answers are grounded in this paper and cite their sources.
Clopidogrel-associated neutropenia in elderly CKD patients warrants hematologic vigilance; this case leaves open broader risk quantification.
Background Clopidogrel is a widely-used antiplatelet and acts as an adenosine diphosphate receptor inhibitor. Neutropenia is a rare but serious adverse effect of clopidogrel. It is unknown whether this adverse effect has any association with impaired kidney function. Case presentation An 80-year-old male with chronic kidney disease was diagnosed with non-ST elevation myocardial infarction and underwent percutaneous coronary intervention. During hospitalization, the patient was diagnosed with contrast-induced nephropathy, treated symptomatically, and discharged with a back-to-baseline creatinine level. Two weeks later, the patient presented to the emergency department with fever and chills. Complete blood count showed leukopenia (0.84 × 10 3 /mm 3 ) and severe neutropenia (0.13 × 10 3 /mm 3 ). Blood cultures were positive for Pseudomonas aeruginosa . Clopidogrel was stopped immediately and switched into ticagrelor. Imipenem and granulocyte colony-stimulating factor were administered to the patient. The patient’s white blood cell and absolute neutrophil count were within the normal range after four days of treatment. The patient was discharged after a 10-day hospitalization, and his complete blood counts were normal during further follow-ups. Conclusions Clopidogrel was the most likely primary cause of neutropenia in our case. The incidence of clopidogrel-induced neutropenia is low and the exact mechanism is not fully explained. We provide suggestions on the management of clopidogrel-associated neutropenia, and summarize all five cases of clopidogrel-induced neutropenia in patients with impaired kidney function.
No takes yet. Share an insight, caveat, or question.
Pan et al. (2022) conducted a case report in Clopidogrel-induced neutropenia (n=1). Clopidogrel was evaluated on Development of severe neutropenia. Clopidogrel therapy in an 80-year-old man with chronic kidney disease resulted in severe neutropenia and sepsis after 55 days, which resolved upon switching to ticagrelor.
Synapse has enriched 10 related papers. Consider them for comparative context: